Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Minister Defends Price Controls In Face Of Industry Opposition

This article was originally published in PharmAsia News

Executive Summary

A minister of the Indian government defends the country's price-control policy as not as punitive on drug makers as they claim. Chemicals and Fertiliser Minister Ram Vilas Paswan denied claims of drug makers, saying they earn enough that they are not adversely affected by price controls. The industry has threatened to stop making certain drugs if controlled profit margins on bulk drugs, lowered in March, are not moved back up. Drug makers note the increased cost of raw materials they use to make their drugs and increased fuel and other costs. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel